Protocol and Clinical Report [Study Per­for­mance]

posted by Ohlbe – France, 2008-10-26 02:08 (6451 d 17:31 ago) – Posting: # 2583
Views: 5,295

Dear Chirag,

According to the ICH GCP guideline, §4.5.1:

The investigator/institution and the sponsor should sign the protocol, or an alternative contract, to confirm agreement.

The protocol should be signed by the investigator or the sponsor. Whether you want somebody else to sign it too is for you to decide, but is not required by the guideline.

Delegation of duties from the sponsor to a CRO should be defined in writing (§5.2.2 in the same guideline), but this will be through a contract (signed by the management of the CRO, not by the investigator), not in the protocol.

Regarding the signature of the report: the ICH E3 guideline only refers to the signature of the investigator or of the sponsor's responsible medical officer.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
156 visitors (0 registered, 156 guests [including 28 identified bots]).
Forum time: 19:40 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5